WISeKey Announces Public Filing of Registration Statement

WISeKey Announces Public Filing of Registration Statement

WISeKey Announces Public Filing of Registration Statement Relating to Proposed Spin-off of its Semiconductor Business Geneva, Switzerland, February 13,......

[Ad hoc announcement pursuant to Art. 53 LR] Transaction in

[Ad hoc announcement pursuant to Art. 53 LR] Transaction in

Basel, 10 February 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the Roche Long Term Foundation acquired 540’000 Roche bearer shares at......

WISeKey’s Semiconductors, NFTs, Post Quantum and Blockchain

WISeKey’s Semiconductors, NFTs, Post Quantum and Blockchain

WISeKey’s Semiconductors, NFTs, Post Quantum and Blockchain Solutions Secure Smart Cities Carlos Moreira, WISeKey’s Founder and CEO, discussed at the......

Continued strong Cresemba® (isavuconazole) sales

Continued strong Cresemba® (isavuconazole) sales

Basel/Allschwil, Switzerland, February 07, 2023 Basilea Pharmaceutica Ltd. (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting......

Sandoz Biologics License Application for proposed

Sandoz Biologics License Application for proposed

Submission supported by comprehensive analytical and clinical data package Denosumab indicated for treating variety of conditions including......

Patients with hidradenitis suppurativa experienced

Patients with hidradenitis suppurativa experienced

In two of the largest Phase III trials conducted in hidradenitis suppurativa (HS), Cosentyx® (secukinumab) treatment response rates continued to improve......

European Commission approves label expansion of Roche’s

European Commission approves label expansion of Roche’s

Hemlibra, already approved for severe haemophilia A in the EU, will now also provide an effective and convenient prophylactic treatment option for people......

Invitation to Idorsia's full year financial results 2022

Invitation to Idorsia's full year financial results 2022

Idorsia will publish its full year financial results 2022 on Tuesday February 7, 2023, at 07:00 CET An investor conference call and webcast will be......

Idorsia submits European marketing authorisation

Idorsia submits European marketing authorisation

The application includes data from the Phase 3 registration study of patients with resistant hypertension, where aprocitentan demonstrated a sustained......

WISeKey Launches eTreeNFT.com Connecting Trees, NFTs and

WISeKey Launches eTreeNFT.com Connecting Trees, NFTs and

WISeKey Launches eTreeNFT.com Connecting Trees, NFTs and Crypto on a Unique Opportunity for Creating New and Totally SustainableAsset-Based Markets for......

  • 1
  • 2
  • 3
  • menu
    menu